Exelon EXC Holds Steady Near Midpoint of Key Support and Resistance Levels Incytes Blood Cancer Drug Combo Shows Promise in Reducing Disease Progression but Side Effects Raise Concerns HUIZ Q1 2025 Earnings Significant EPS Miss Amidst Stock Uptick Sunshine Biopharma Secures Patent for Novel Coronavirus Treatment Compounds